The dipeptidyl peptidase-4 inhibitor, linagliptin, improves cognitive impairment in streptozotocin-induced diabetic mice by inhibiting oxidative stress and microglial activation.

by Makoto Ide, Noriyuki Sonoda, Tomoaki Inoue, Shinichiro Kimura, Yohei Minami, Hiroaki Makimura, Eiichi Hayashida, Fuminori Hyodo, Mayumi Yamato, Ryoichi Takayanagi, Toyoshi Inoguchi
Published 2020-01-01